Efficacy of loratadine compared with fexofenadine or placebo for the treatment of seasonal allergic rhinitis

Clinical Drug Investigation

Volumn 21, Issue 8, 2001, Pages 571-578

  Kaiser, H B ^a   Rooklin, A ^b   Spangler, D ^c   Capano, D ^d  

^a Clinical Research Institute   (United States)

^b Allergy Research Associates   (United States)

^c Atlanta Allergy and Immunology Research Foundation   (United States)

^d Integrated Therapeutics Group Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FEXOFENADINE; LORATADINE; PLACEBO;

ADOLESCENT; ADULT; ALLERGIC RHINITIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NIGHT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SEASONAL VARIATION; SYMPTOMATOLOGY;

EID: 0034866922     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200121080-00006     Document Type: Article

References (17)

1. National guidelines needed to manage rhinitis and prevent complications
2. Learning impairment and allergic rhinitis
3. Effects of allergy season on mood and cognitive function
4. Diagnosis and management of rhinitis: Complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology
5. Pharmacokinetic overview of oral second-generation HI antihistamines
6. Consensus statement on the treatment of allergic rhinitis
7. Comparison of the efficacy and safety of loratadine, terfenadine, and placebo in the treatment of seasonal allergic rhinitis
8. Efficacy and safety of loratadine (10 mg once daily), terfenadine (60 mg twice daily), and placebo in the treatment of seasonal allergic rhinitis
9. Safety and efficacy of once-daily fexofenadine HC1 in the treatment of autumn seasonal allergic rhinitis
10. Effectiveness and safety of fexofenadine, a new nonsedating H1-receptor antagonist, in the treatment of fall allergies
11. Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis
12. Efficacy and tolerability of loratadine versus fexofenadine in the treatment of seasonal allergic rhinitis: A double-blind comparison with crossover treatment of nonresponders
13. Onset of action, efficacy, and safety of a single dose of fexofenadine hydrochloride for ragweed allergy using an environmental exposure unit
14. Onset of action and efficacy of terfenadine, astemizole, cetirizine, and loratadine for the relief of symptoms of allergic rhinitis
15. Onset of action of loratadine and placebo and other efficacy variables in patients with seasonal allergic rhinitis